African Journal of Biotechnology

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

 

Afr. J. Biotechnol.


Vol. 5 No. 19



Viewing options:


 • Abstract
 • Full text
 • Reprint (PDF) (90K)

Search Pubmed for articles by:

 

Bessong PO

Obi CL

 


Other links:


PubMed Citation


Related articles in PubMed

 

African Journal of Biotechnology Vol. 5 (19), pp. 1693-1699, 2 October 2006   

ISSN 1684–5315 © 2006 Academic Journals        

 

 

Review

 

Ethnopharmacology of human immunodeficiency virus in South Africa–a minireview

 

Pascal Obong Bessong*, Chikwelu Larry Obi

 

Department of Microbiology, University of Venda, Thohoyandou, South Africa.

 

*Corresponding authors E-mail: bessong@univen.ac.za

 

Accepted 9 August, 2006

 
    Abstract

 

 

 

Infection with the human immunodeficiency virus (HIV), the etiologic agent of acquired immune deficiency syndrome (AIDS), continues to pose an unprecedented public health problem of enormous proportions worldwide. Current treatment options for HIV/AIDS have not been satisfactory and the quest for effective curative or preventive therapies goes on. Plants are increasingly seen as an alternative source for the discovery of novel anti-HIV molecules. Africa, particularly southern Africa, endowed with a rich diversity of medicinal plants, represents the region of the world worse hit by HIV. Anecdotal evidence of the therapeutic benefits to AIDS patients of some plant-derived preparations abound. This mini-review takes a look at the evaluations of South African medicinal plants to determine their effects on HIV/AIDS, and the initial attempts at the isolation and characterization of putative anti-HIV molecules.

 

Key words: Human immunodeficiency virus, Medicinal plants, South Africa.

 

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Copyright © 2006 by Academic Journals.